Sexual satisfaction · Men with COPD
1 finding from 1 review
Effect on later sexual function · Men with COPD
1 finding from 1 review
Adverse events (all cause) · Men with COPD
Testosterone therapy showed no clear difference in adverse events (all cause) compared with placebo (low certainty).
1 finding from 1 review
Treatment failure Need to intensify therapy/ED or hospital admission · exacerbations of COPD
Systemic corticosteroid leads to lower treatment failure Need to intensify therapy/ED or hospital admission compared with placebo (high certainty).
1 finding from 1 review
Relapse Treatment for AE of COPD or hospital re‐admission · exacerbations of COPD
Systemic corticosteroid showed no clear difference in relapse Treatment for AE of COPD or hospital re‐admission compared with placebo (moderate certainty).
1 finding from 1 review
FEV1 · exacerbations of COPD
1 finding from 1 review
Breathlessness ‐ early effect VAS 0‐10. Scale from: 0 to 10. · exacerbations of COPD
1 finding from 1 review
Adverse drug reactions · exacerbations of COPD
Systemic corticosteroid leads to higher adverse drug effect compared with placebo (high certainty).
1 finding from 1 review
Hyperglycaemia · exacerbations of COPD
Systemic corticosteroid leads to higher hyperglycaemia compared with placebo (high certainty).
1 finding from 1 review
Frequency and duration of exacerbations · people with bronchiectasis
The review found no eligible studies for this question.
1 finding from 1 review
Adverse events · people with bronchiectasis
The review found no eligible studies for this question.
1 finding from 1 review
Health‐related quality of life · people with bronchiectasis
The review found no eligible studies for this question.
1 finding from 1 review
Symptoms sputum colour Scale used not reported · people with bronchiectasis
RhDNase showed no clear difference in symptoms sputum colour Scale used not reported compared with placebo (low certainty).
1 finding from 1 review
Deaths · people with bronchiectasis
RhDNase showed no clear difference in deaths compared with placebo (low certainty).
1 finding from 1 review
Lung function: FEV1 mL (percentage change from baseline) · people with bronchiectasis
RhDNase showed no clear difference in lung function % change FEV1 compared with placebo (low certainty).
1 finding from 1 review
Hospital admissions · people with bronchiectasis
The review found no eligible studies for this question.
1 finding from 1 review
Adverse events · people with bronchiectasis
Bromhexine showed no clear difference in adverse events compared with placebo (low certainty).
1 finding from 1 review
Health‐related quality of life · people with bronchiectasis
The review found no eligible studies for this question.
1 finding from 1 review
Symptoms difficulty in expectoration · people with bronchiectasis
Bromhexine showed no clear difference in symptoms difficulty in expectoration compared with placebo (low certainty).
1 finding from 1 review
Deaths · people with bronchiectasis
The review found no eligible studies for this question.
1 finding from 1 review